ConductScience.org, home

Paper17519297

Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.

Lam JY and 2 others. Ann Pharmacother, 2007. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Papers, record 17519297. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519297

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants.
PubMed
Journal
Ann Pharmacother
PubMed
Year
2007
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.59
iCite
Revised in PubMed
2018-12-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lam JYJenny Y
2Freeman MKMaisha Kelly
3Cates MEMarshall E

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
Benzhydryl CompoundsMajor topic
Central Nervous System StimulantsMajor topic
DepressionMajor topic
FatigueMajor topic
Humans
Modafinil

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
34907284Cognitive profiling and proteomic analysis of the modafinil analogue S-CE-123 in experienced aged rats.Sci Rep2021https://conductscience.org/library/papers/34907284PubMed
32770257Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.Psychopharmacology (Berl)2020https://conductscience.org/library/papers/32770257PubMed
32049857Moxibustion at 'Danzhong' (RN17) and 'Guanyuan' (RN4) for fatigue symptom in patients with depression: Study protocol clinical trial (SPIRIT Compliant).Medicine (Baltimore)2020https://conductscience.org/library/papers/32049857PubMed
31316379The Novel Atypical Dopamine Uptake Inhibitor (S)-CE-123 Partially Reverses the Effort-Related Effects of the Dopamine Depleting Agent Tetrabenazine and Increases Progressive Ratio Responding.Front Pharmacol2019https://conductscience.org/library/papers/31316379PubMed
30209181The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation.Pharmacol Rev2018https://conductscience.org/library/papers/30209181PubMed
29628879Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research.Front Behav Neurosci2018https://conductscience.org/library/papers/29628879PubMed
27189581Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.Brain2016https://conductscience.org/library/papers/27189581PubMed
22043293The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors.PLoS One2011https://conductscience.org/library/papers/22043293PubMed
19783386Modafinil does not serve as a reinforcer in cocaine abusers.Drug Alcohol Depend2010https://conductscience.org/library/papers/19783386PubMed
19565292[Neuro-enhancement. Brain doping].Nervenarzt2009https://conductscience.org/library/papers/19565292PubMed
19255746Depression-like deficits in rats improved by subchronic modafinil.Psychopharmacology (Berl)2009https://conductscience.org/library/papers/19255746PubMed
19170404Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications.Dialogues Clin Neurosci2008https://conductscience.org/library/papers/19170404PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17519297

GET https://conductscience.org/api/papers/v1/17519297/authors